Clinical Trial Update: Diabetes in Neuropsychiatric Disorders [Phase 1, Phase 2]

View source ↗

Summary

An NIDDK-sponsored Phase 1/2 trial investigating diabetes in neuropsychiatric disorders with schizophrenia has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Schizophrenia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-11-06